Mechanism of action of emergency contraception

被引:45
作者
Gemzell-Danielsson, Kristina [1 ]
机构
[1] Karolinska Inst, Dept Womens & Childrens Hlth, Div Obstet & Gynecol, Karolinska Univ Hosp, S-17176 Stockholm, Sweden
基金
英国医学研究理事会;
关键词
Emergency contraception; Levonorgestrel; Endometrial function; Implantation; Ovulation; Mifepristone; Ulipristal acetate; EARLY LUTEAL-PHASE; PROGESTERONE-RECEPTOR MODULATOR; MIDCYCLE GONADOTROPIN SURGE; LOW-DOSE MIFEPRISTONE; HORMONAL PARAMETERS; ACROSOME REACTION; HUMAN ENDOMETRIUM; BLEEDING PATTERN; OVARIAN-FUNCTION; LEVONORGESTREL;
D O I
10.1016/j.contraception.2010.05.004
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
A major barrier to the widespread acceptability and use of emergency contraception (EC) are concerns regarding the mechanisms of action of EC methods. Today, levonorgestrel (LNG) in a single dose of 1.5 mg taken within 120 h of an unprotected intercourse is the most widely used EC method worldwide. It has been demonstrated that LNG-EC acts through an effect on follicular development to delay or inhibit ovulation but has no effect once luteinizing hormone has started to increase. Thereafter, LNG-EC cannot prevent ovulation and it does not prevent fertilization or affect the human fallopian tube. LNG-EC has no effect on endometrial development or function. In an in vitro model, it was demonstrated that LNG did not interfere with blastocyst function or implantation. (C) 2010 Elsevier Inc. All rights reserved.
引用
收藏
页码:404 / 409
页数:6
相关论文
共 64 条
[1]   The in vitro effect of levonorgestrel on the acrosome reaction of human spermatozoa from fertile men [J].
Bahamondes, L ;
Nascimento, JAA ;
Munuce, MJ ;
Fazano, F ;
Faúndes, A .
CONTRACEPTION, 2003, 68 (01) :55-59
[2]   EVIDENCE FOR A CRITICAL ROLE OF PROGESTERONE IN THE REGULATION OF THE MIDCYCLE GONADOTROPIN SURGE AND OVULATION [J].
BATISTA, MC ;
CARTLEDGE, TP ;
ZELLMER, AW ;
NIEMAN, LK ;
MERRIAM, GR ;
LORIAUX, DL .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1992, 74 (03) :565-570
[3]  
BATISTA MC, 1994, FERTIL STERIL, V62, P28
[4]  
BERER M, 1995, CONTRACEPTION, V52, P211
[5]   Development of the selective progesterone receptor modulator CDB-2914 for clinical indications [J].
Blithe, DL ;
Nieman, LK ;
Blye, RP ;
Stratton, P ;
Passaro, M .
STEROIDS, 2003, 68 (10-13) :1013-1017
[6]   Effect of two antiprogestins (mifepristone and onapristone) on endometrial factors of potential importance for implantation [J].
Cameron, ST ;
Critchley, HOD ;
Buckley, CH ;
Kelly, RW ;
Baird, DT .
FERTILITY AND STERILITY, 1997, 67 (06) :1046-1053
[7]  
Cheng L, 2008, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001324.pub3, 10.1002/14651858.CD001324.pub4]
[8]   Effect of mifepristone and levonorgestrel on expression of steroid receptors in the human Fallopian tube [J].
Christow, A ;
Sun, X ;
Gemzell-Danielsson, K .
MOLECULAR HUMAN REPRODUCTION, 2002, 8 (04) :333-340
[9]   Progesterone receptor modulator for emergency contraception - A randomized controlled trial [J].
Creinin, Mitchell D. ;
Schlaff, William ;
Archer, David F. ;
Wan, Livia ;
Frezieres, Ron ;
Thomas, Michael ;
Rosenberg, Michael ;
Higgins, James .
OBSTETRICS AND GYNECOLOGY, 2006, 108 (05) :1089-1097
[10]   Pituitary-ovarian function following the standard levonorgestrel emergency contraceptive dose or a single 0.75-mg dose given on the days preceding ovulation [J].
Croxatto, HB ;
Brache, V ;
Pavez, M ;
Cochon, L ;
Forcelledo, ML ;
Alvarez, F ;
Massai, R ;
Faundes, A ;
Salvatierra, AM .
CONTRACEPTION, 2004, 70 (06) :442-450